What is Cepheid?
Founded in 1996, Cepheid specializes in the development, manufacturing, and marketing of sophisticated molecular systems and diagnostic tests. The company's core innovation lies in automating complex manual procedures, enabling institutions of all sizes to perform advanced genetic testing for identifying organisms and diagnosing genetic-based diseases. Cepheid's solutions are designed to streamline laboratory workflows and improve diagnostic accuracy, positioning it as a key player in the rapidly evolving field of molecular diagnostics and medical technology.
How much funding has Cepheid raised?
Cepheid has raised a total of $33M across 4 funding rounds:
Angel/Seed
$2.5M
Series A
$3.2M
Series B
$8.3M
Series C
$19.1M
Angel/Seed (1996): $2.5M with participation from Medtronic, Inc. and Advanced Technology Ventures
Series A (1997): $3.2M, investors not publicly disclosed
Series B (1998): $8.3M, investors not publicly disclosed
Series C (2000): $19.1M, investors not publicly disclosed
Key Investors in Cepheid
Medtronic, Inc.
Medtronic, Inc. is a global leader in medical technology, focusing on developing innovative therapies for chronic diseases. Their investment in Cepheid aligns with their broad portfolio of medical devices and therapies aimed at improving patient outcomes.
Advanced Technology Ventures
Advanced Technology Ventures (ATV) is a bi-coastal venture capital firm with extensive experience in building emerging-growth technology companies. Their backing of Cepheid suggests a strategic focus on innovative healthcare and IT infrastructure solutions.
What's next for Cepheid?
The substantial enterprise-level backing and recent strategic investment signal a strong growth trajectory for Cepheid. This capital infusion is likely to accelerate research and development efforts, potentially leading to new diagnostic assays and expanded applications for its existing platforms. Furthermore, the financing may support strategic partnerships or acquisitions aimed at broadening market reach and solidifying Cepheid's competitive advantage in the global diagnostics sector. The company appears poised for continued expansion and innovation in its mission to enhance healthcare through advanced genetic testing.
See full Cepheid company page
